Meta-analysis of results from eight randomized, placebo-controlled trials on the effect of cilostazol on patients with intermittent claudication.
about
Cilostazol for intermittent claudicationCilostazol for peripheral arterial diseasePeripheral Arterial Disease in Patients with Type 2 Diabetes MellitusComparative Efficacy and Safety of Different Antiplatelet Agents for Prevention of Major Cardiovascular Events and Leg Amputations in Patients with Peripheral Arterial Disease: A Systematic Review and Network Meta-AnalysisAnti-platelet therapy: phosphodiesterase inhibitors.Practice-based evidence: profiling the safety of cilostazol by text-mining of clinical notesDesign of the START-trial: STimulation of ARTeriogenesis using subcutaneous application of GM-CSF as a new treatment for peripheral vascular disease. A randomized, double-blind, placebo-controlled trial.Current approach to the diagnosis and treatment of femoral-popliteal arterial disease. A systematic reviewOpen-Label Phase I Clinical Study to Assess the Safety and Efficacy of Cilostazol in Patients Undergoing Internal Carotid Artery Stent PlacementA pooled analysis of the durability and predictors of treatment response of cilostazol in patients with intermittent claudication.Peripheral artery disease: current insight into the disease and its diagnosis and management.Office evaluation of leg pain.Profile of atherosclerotic risk factors and management in patients of peripheral arterial disease at a tertiary care teaching hospital of north India.Platelets, atherosclerosis and the endothelium: new therapeutic targets?Antiplatelet drugs: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice GuidelinesOptimal management of peripheral arterial disease for the non-specialistCan endovascular therapy of infrainguinal disease for claudication be justified?Cilostazol: improving walking distance in patients with intermittent claudication.Peripheral arterial disease of the lower extremities.Leg ulcers and pain: a review.Comparison of the results of percutaneous transluminal angioplasty and stenting with medical treatment for claudicants who have superficial femoral artery occlusive disease.Optimal medical management of peripheral arterial disease.Management of peripheral arterial disease in the elderly: focus on cilostazolTargeting phosphodiesterases in anti-platelet therapyAntiplatelet Effect of Sequential Administration of Cilostazol in Patients with Acetylsalycilic Acid Resistance.Peripheral arterial disease in the elderly.Peripheral arterial disease: Epidemiology, natural history, diagnosis and treatment.Pharmacologic therapy for intermittent claudication.Treatment strategies for peripheral artery disease.The burden of peripheral artery disease and the role of antiplatelet therapy.Cilostazol and atherogenic dyslipidemia: a clinically relevant effect?The role of antiplatelets in hypertension and diabetes mellitus.Beyond aspirin and clopidogrel: is there a need for additional antiplatelet therapy in ACS?Peripheral artery disease. Part 2: medical and endovascular treatment.Current therapeutic strategies to mitigate the eNOS dysfunction in ischaemic stroke.Supervised exercise therapy for intermittent claudication: current status and future perspectives.Preventive aspects in peripheral artery disease.Medical management for chronic atherosclerotic peripheral arterial disease.Endothelial shear stress and blood viscosity in peripheral arterial disease.Pharmacological treatment and therapeutic perspectives of metabolic syndrome.
P2860
Q24193019-614854A3-E529-4D0D-8205-7D9E188AEDD2Q24242765-FA2F9D23-72B3-4A12-BFB7-A43AE67E5CE5Q26795374-57F1625C-2DA0-4C6F-8B57-A6AB53C0D5BEQ26798134-58CC9866-DB7C-4ECB-B21E-B3D714B94E52Q27687228-19FF1DAC-4FAC-49C4-BA9D-FFBA6F50F650Q28533275-60CAD423-6EAE-4FA8-86E3-79455762546EQ33198730-0A4D3C5B-7902-47C0-8939-E245EB32E631Q33743880-A34903CE-4859-444B-92FB-5DBCCBF16718Q33781981-EDC0D06C-193E-4651-AB29-818A342430B9Q33903841-3601A5B7-1060-4E58-A13C-EA780664BEF5Q33951581-45F85CAF-0199-43EC-8B74-F912E5D9057CQ34563715-AA4F9D37-72BB-43FE-82A3-BE4640C9A4A8Q34949365-937EB56B-FD9C-4943-9757-8C3E8CBB3A4EQ35570940-4DC8B262-D883-4CA9-BBAB-93D21EEAECDEQ35752619-A53B9786-1EC5-40B2-BE4E-C51B98E1D747Q35761784-43378754-D5D1-419B-9EC7-F99B8B9DB8FDQ35777360-64E6743A-92E7-4C7A-A5B3-242B7E5E837CQ35821880-8F1AB337-06E2-4032-9BF5-1046DFC72096Q35990502-2162E2D6-07D3-4379-96A2-E4638B81F704Q36113676-8ABA9DB5-9C92-4971-AD0B-E6F34977D77EQ36587019-7CF3A172-0D44-460B-8093-8F122ADAFD36Q36588669-E0B6D020-7365-44D1-9C51-0B9C53C71B25Q36892864-0CCCFA95-B99A-4BBE-8EE3-83D0EB6608CDQ36929627-A312112A-CE87-425F-8E72-9DECFE21D581Q36946112-E66F6909-CE74-4A84-8B78-464E42FB30AAQ37069056-0D713F49-73D6-476E-B7EE-1E349C258D41Q37321632-E08E60EB-02F3-4F48-9DF2-11E4E25F82C4Q37461418-9D301136-AC4E-45DD-A9E0-5D52AA92CFA5Q37519704-B821E79C-C556-40B9-92D6-FB39F4C0BBE1Q37566082-155CCABC-6B55-472A-811F-8E1E731A8110Q37834033-6FCE8918-15A2-4CE9-9ABA-29528B1B1B03Q37861894-D9806108-BFB9-4B16-8C1B-143D86DE93BDQ37878982-22E0C865-404B-4D2F-BA53-C35C352BA824Q37889106-EBC4DF2D-DB42-47FB-BB6B-21F547F9A2E2Q37971308-EBCA5634-9742-415B-ACAC-ADDED7A977D9Q37983543-FB519216-5711-48DA-9556-579E1A60DDCBQ37984281-D4707F57-EE33-4B29-A3C4-0FE170122163Q38050495-69682E33-E56A-4C2F-B026-D678DC603014Q38187356-5A5DD693-2B0D-4E13-8911-C9BA2E44F7D3Q38262435-AC766905-3ED6-44BF-B3E4-5F101BA0437F
P2860
Meta-analysis of results from eight randomized, placebo-controlled trials on the effect of cilostazol on patients with intermittent claudication.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh-hant
name
Meta-analysis of results from ...... ith intermittent claudication.
@en
Meta-analysis of results from ...... ith intermittent claudication.
@nl
type
label
Meta-analysis of results from ...... ith intermittent claudication.
@en
Meta-analysis of results from ...... ith intermittent claudication.
@nl
prefLabel
Meta-analysis of results from ...... ith intermittent claudication.
@en
Meta-analysis of results from ...... ith intermittent claudication.
@nl
P2093
P1476
Meta-analysis of results from ...... ith intermittent claudication.
@en
P2093
Paul D Thompson
Peter Zhang
Richard Zimet
William P Forbes
P304
P356
10.1016/S0002-9149(02)02869-2
P407
P577
2002-12-01T00:00:00Z